Etilevodopa hydrochloride
CAS No. 39740-30-2
Etilevodopa hydrochloride( Etilevodopa HCl | ?L-DOPA ethyl ester | Levodopa ethyl ester )
Catalog No. M27765 CAS No. 39740-30-2
Etilevodopa HCl is a prodrug of levodopa. It also has greater gastric solubility and significant brain penetration.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 37 | Get Quote |
|
| 10MG | 59 | Get Quote |
|
| 25MG | 119 | Get Quote |
|
| 50MG | 177 | Get Quote |
|
| 100MG | 299 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameEtilevodopa hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionEtilevodopa HCl is a prodrug of levodopa. It also has greater gastric solubility and significant brain penetration.
-
DescriptionEtilevodopa HCl is a prodrug of levodopa. It also has greater gastric solubility and significant brain penetration.
-
In VitroEtilevodopa (L-Dopa ethyl ester) hydrochloride passes unchanged through the stomach to the duodenum, where it is rapidly hydrolyzed by local esterases to Levodopa and ethanol, and is subsequently absorbed into the blood stream as Levodopa.Compared with standard Levodopa, Etilevodopa hydrochloride has greater solubility in the stomach, faster passage to the small intestine, and a shortened time to maximum Levodopa concentration.
-
In Vivo——
-
SynonymsEtilevodopa HCl | ?L-DOPA ethyl ester | Levodopa ethyl ester
-
PathwayOthers
-
TargetOther Targets
-
RecptornNOS/NOS1 AP
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number39740-30-2
-
Formula Weight261.7
-
Molecular FormulaC11H16ClNO4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?H2O : 125 mg/mL (477.65 mM)
-
SMILESCl.CCOC(=O)[C@@H](N)Cc1ccc(O)c(O)c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Wan-Hung Lee, et al. ZLc002, a putative small-molecule inhibitor of nNOS interaction with NOS1AP, suppresses inflammatory nociception and chemotherapy-induced neuropathic pain and synergizes with paclitaxel to reduce tumor cell viability. Mol Pain. 2018 Jan-Dec;14:1744806918801224.
molnova catalog
related products
-
1,7-Bis(4-hydroxyphe...
(4Z,6E)-5-hydroxy-1,7-bis(4-hydroxyphenyl)hepta-4,6-dien-3-one shows growth inhibitory activity in vitro versus bloodstream forms of African trypanosomes, with the IC(50) value in the range of 1-3 microg/mL.
-
CEF27,Epstein-Barr V...
HLA-A*0301-restricted epitope from Epstein-Barr Virus , EBV BRLF-1 (148-156).
-
LY-3475070
LY-3475070 is a potent and selective CD73 inhibitor with an IC50 of 28 nM, and its use alone or in combination with pembrolizumab is currently being tested in patients with advanced cancer.
Cart
sales@molnova.com